New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults worldwide who heard about Novo Nordisk’s remarkable brand name drug Ozempic and how it can help you reduce your body weight.

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly diving into the opportunity to make anti-obesity products. This article looks into key players in the arena.